SANA - Sana Biotechnology, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
6.35 -0.15 (-2.36%)	0.0 (0.0%)	0.02 (0.32%)	0.16 (2.65%)	-0.15 (-2.36%)	1.41 (31.15%)	-0.01 (-0.24%)	0.29 (4.91%)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.39
Diluted EPS:: -0.39
Basic P/E:: -15.8974
Diluted P/E:: -15.8974
RSI(14) 1m:: 50.0
VWAP:: 6.2
RVol:: 0.0286

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	5.93 +0.08 (+1.34%)	Oct 15 16:19
1m	Price increase 1m	5.93 +0.08 (+1.34%)	Oct 15 16:19
1m	Price increase 1m	5.93 +0.08 (+1.34%)	Oct 15 16:19
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17